COPHy 2024: Should all patients with idiopathic intracranial hypertension have a lumbar puncture?
March 16th 2024COPHy
Andrew G. Lee, MD, outlines his stance on whether all patients with idiopathic intracranial hypertension should have a lumbar puncture, emphasizing clinical judgment and treatment strategies.
Intraocular inflammation: A major risk factor resulting from use of anti-complement agents for GA
March 15th 2024COPHy
The good news for patients is that GA is transitioning from an untreatable disease to a potentially treatable one with development of new therapies to reduce the growth rate, and use of anti-complement therapies have caused the growth rate of GA lesions to decrease.
EnVision Summit 2024: Using the miCOR 700 device for phacoemulsification cataract surgery
February 21st 2024EnVision Summit
Anthony Mai, MD, shared results from using the miCOR 700 device, which is a new device from Zeiss, for phacoemulsification cataract surgery at the EnVision Summit 2024. He spoke with Peg Achenbach, OD, FAAO, Executive Director/Global Ambassador Strategies, Ophthalmology and Optometry at MJH Life sciences, on location in Puerto Rico to share more about his presentation.
EnVision Summit 2024: Leadership talk guides women in eye care through personal IPO journey
February 16th 2024EnVision Summit
Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Angiogenesis 2024: Utilizing longitudinal AI-based fluid quantification for at-home monitoring
February 3rd 2024Angiogenesis
In conversation with Ophthalmology Times Europe, Anat Loewenstein, MD, illuminates the outcomes of using an AI-based fluid quantification for remote retina monitoring and analysis.